Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PROLYL HYDROXYLASE INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/061172
Kind Code:
A1
Abstract:
Disclosed is a prolyl hydroxylase inhibitor, which belongs to the technical field of medicines. The present invention provides a pyridino-triazole compound having a structure represented by the formula below. The pyridino-triazole compound has relatively high prolyl hydroxylase inhibitory activity and EPO induction activity, can effectively treat and prevent HIF-related and/or EPO-related diseases, and provides a new thought for dealing with diseases such as anemia, ischemia, and hypoxia.

Inventors:
TANG HAITAO (CN)
TANG FAN (CN)
GE HAITAO (CN)
Application Number:
PCT/CN2023/119468
Publication Date:
March 28, 2024
Filing Date:
September 18, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUZHONG PHARMACEUTICAL GROUP CO LTD (CN)
JIANGSU SUZHONG PHARMACEUTICAL RES INSTITUTE CO LTD (CN)
International Classes:
C07D471/04; A61K31/4375; A61K31/5377; A61P7/06; A61P9/10
Domestic Patent References:
WO2016104451A12016-06-30
WO2022150623A12022-07-14
Foreign References:
CN116496269A2023-07-28
CN102471337A2012-05-23
US20100303928A12010-12-02
CN101460497A2009-06-17
Other References:
LIU, SIFAN ET AL.: "Design and Synthesis of Proline Hydroxylase Domain Inhibitor", SYNTHETIC CHEMISTRY RESEARCH, vol. 6, no. 1, 6 February 2018 (2018-02-06), pages 1 - 7, ISSN: 2332-7960
DATABASE Registry CAS; 29 March 2018 (2018-03-29), ANONYMOUS : "Glycine, N-[[5-(2-cyclohexylpro poxy)-7-hydroxy[1,2,4]triaz olo[1,5- a]pyridin-8-yl]carbonyl]-", XP093148763, retrieved from STN Database accession no. 2201926-56-7
Attorney, Agent or Firm:
JJS INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: